Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

VR and brain training tested as Opioid-Free pain relief

NCT ID NCT04551092

Symptom relief Sponsor: Quantum Applied Science & Research, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a system that combines virtual reality (VR) with brain training (neurofeedback) to help people manage chronic back pain without using opioid drugs. Eleven adults with severe back pain took part in up to 20 sessions. Researchers measured how well patients tolerated the device and whether their pain changed over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

11 people

The number who actually took part.

Started

Jan 2021

Finished

Mar 2022

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

17 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Chronic back pain that can be of multifactorial etiology inclusive of axial and radicular back pain * Report a Numerical Rating Scale (NRS, or Visual Analog Score VAS) score of greater than 6/10 * Must be willing to for the duration of the study make no pharmacological adjustments or have additional Interventional therapies, as reported by the patient * Must have the cognitive capacity to provide consent/assent * Must be able to sit up in a chair during the recording session * Must demonstrate understanding of the protocol, its purpose and subject participation * Must be fluent in English Exclusion Criteria: * Measured head size too small or too large for the EEG equipment * Any significant skull defect * History of a recent craniotomy (within the last six months) * Any signs of scalp inflammation, irritation, or abnormal skin conditions * History of epilepsy or seizures * Known allergies to any material to be used in this project * Sight disabilities that make participation impractical * Hair styles with thick braids or dread locks

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pain management are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

agnosia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pain management

Contacts and locations

Locations

  • Altman Clinical and Translational Research Institute

    San Diego, California, 92037, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.